{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:01:09Z","timestamp":1769580069054,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T00:00:00Z","timestamp":1541548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"La\u00e7o","award":["La\u00e7o Grant 2014"],"award-info":[{"award-number":["La\u00e7o Grant 2014"]}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/SAU-GMG\/120049\/2010-FCOMP-01-0124-FEDER-021209"],"award-info":[{"award-number":["PTDC\/SAU-GMG\/120049\/2010-FCOMP-01-0124-FEDER-021209"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PEst-C\/SAU\/LA0003\/2013"],"award-info":[{"award-number":["PEst-C\/SAU\/LA0003\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["NORTE-01-0145-FEDER-000029"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-000029"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-016390"],"award-info":[{"award-number":["POCI-01-0145-FEDER-016390"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/75705\/2011"],"award-info":[{"award-number":["SFRH\/BPD\/75705\/2011"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/100380\/2014"],"award-info":[{"award-number":["SFRH\/BD\/100380\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/104208\/2014"],"award-info":[{"award-number":["SFRH\/BPD\/104208\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/90303\/2012"],"award-info":[{"award-number":["SFRH\/BPD\/90303\/2012"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["Programa IFCT 2013 (FCT Investigator)"],"award-info":[{"award-number":["Programa IFCT 2013 (FCT Investigator)"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12964-018-0286-2","type":"journal-article","created":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T08:02:23Z","timestamp":1541577743000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["SRC inhibition prevents P-cadherin mediated signaling and function in basal-like breast cancer cells"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9698-9233","authenticated-orcid":false,"given":"Ana Sofia","family":"Ribeiro","sequence":"first","affiliation":[]},{"given":"Ana Rita","family":"Nobre","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Mendes","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Almeida","sequence":"additional","affiliation":[]},{"given":"Andr\u00e9 Filipe","family":"Vieira","sequence":"additional","affiliation":[]},{"given":"B\u00e1rbara","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Filomena A.","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Monteiro","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Pol\u00f3nia","sequence":"additional","affiliation":[]},{"given":"Martina","family":"Fonseca","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Miguel","family":"Sanches","sequence":"additional","affiliation":[]},{"given":"Nuno C.","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Seruca","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Paredes","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,11,7]]},"reference":[{"key":"286_CR1","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98:10869\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"286_CR2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747\u201352.","journal-title":"Nature"},{"key":"286_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/00313020802563510","volume":"41","author":"EA Rakha","year":"2009","unstructured":"Rakha EA, Ellis IO. Triple-negative\/basal-like breast cancer: review. Pathology. 2009;41:40\u20137.","journal-title":"Pathology"},{"key":"286_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s12282-009-0150-8","volume":"16","author":"Y Yamamoto","year":"2009","unstructured":"Yamamoto Y, Ibusuki M, Nakano M, Kawasoe T, Hiki R, Iwase H. Clinical significance of basal-like subtype in triple-negative breast cancer. Breast Cancer. 2009;16:260\u20137.","journal-title":"Breast Cancer"},{"key":"286_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/bcr1774","volume":"9","author":"J Paredes","year":"2007","unstructured":"Paredes J, Correia AL, Ribeiro AS, Albergaria A, Milanezi F, Schmitt FC. P-cadherin expression in breast cancer: a review. Breast Cancer Res. 2007;9:214.","journal-title":"Breast Cancer Res"},{"key":"286_CR6","first-page":"963","volume":"25","author":"B Sousa","year":"2010","unstructured":"Sousa B, Paredes J, Milanezi F, Lopes N, Martins D, Dufloth R, Vieira D, Albergaria A, Veronese L, Carneiro V, et al. P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study. Histol Histopathol. 2010;25:963\u201374.","journal-title":"Histol Histopathol"},{"key":"286_CR7","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1158\/1078-0432.CCR-05-0059","volume":"11","author":"J Paredes","year":"2005","unstructured":"Paredes J, Albergaria A, Oliveira JT, Jeronimo C, Milanezi F, Schmitt FC. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clin Cancer Res. 2005;11:5869\u201377.","journal-title":"Clin Cancer Res"},{"key":"286_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s004280100487","volume":"440","author":"J Paredes","year":"2002","unstructured":"Paredes J, Milanezi F, Viegas L, Amendoeira I, Schmitt F. P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast. Virchows Arch. 2002;440:16\u201321.","journal-title":"Virchows Arch"},{"key":"286_CR9","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/onc.2009.338","volume":"29","author":"AS Ribeiro","year":"2010","unstructured":"Ribeiro AS, Albergaria A, Sousa B, Correia AL, Bracke M, Seruca R, Schmitt FC, Paredes J. Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells. Oncogene. 2010;29:392\u2013402.","journal-title":"Oncogene"},{"key":"286_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3389\/fonc.2014.00045","volume":"4","author":"AS Ribeiro","year":"2014","unstructured":"Ribeiro AS, Paredes J. P-cadherin linking breast Cancer stem cells and invasion: a promising marker to identify an \u201cintermediate\/metastable\u201d EMT state. Front Oncol. 2014;4:371.","journal-title":"Front Oncol"},{"key":"286_CR11","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/path.4143","volume":"229","author":"AS Ribeiro","year":"2013","unstructured":"Ribeiro AS, Sousa B, Carreto L, Mendes N, Nobre AR, Ricardo S, Albergaria A, Cameselle-Teijeiro JF, Gerhard R, Soderberg O, et al. P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model. J Pathol. 2013;229:705\u201318.","journal-title":"J Pathol"},{"key":"286_CR12","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1186\/1471-2407-14-734","volume":"14","author":"B Sousa","year":"2014","unstructured":"Sousa B, Ribeiro AS, Nobre AR, Lopes N, Martins D, Pinheiro C, Vieira AF, Albergaria A, Gerhard R, Schmitt F, et al. The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype. BMC Cancer. 2014;14:734.","journal-title":"BMC Cancer"},{"key":"286_CR13","doi-asserted-by":"publisher","first-page":"679","DOI":"10.18632\/oncotarget.1459","volume":"5","author":"AF Vieira","year":"2014","unstructured":"Vieira AF, Ribeiro AS, Dionisio MR, Sousa B, Nobre AR, Albergaria A, Santiago-Gomez A, Mendes N, Gerhard R, Schmitt F, et al. P-cadherin signals through the laminin receptor alpha6beta4 integrin to induce stem cell and invasive properties in basal-like breast cancer cells. Oncotarget. 2014;5:679\u201392.","journal-title":"Oncotarget"},{"key":"286_CR14","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/stem.1075","volume":"30","author":"AF Vieira","year":"2012","unstructured":"Vieira AF, Ricardo S, Ablett MP, Dionisio MR, Mendes N, Albergaria A, Farnie G, Gerhard R, Cameselle-Teijeiro JF, Seruca R, et al. P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer. Stem Cells. 2012;30:854\u201364.","journal-title":"Stem Cells"},{"key":"286_CR15","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1158\/0008-5472.CAN-04-1949","volume":"65","author":"VG Brunton","year":"2005","unstructured":"Brunton VG, Avizienyte E, Fincham VJ, Serrels B, Metcalf CA 3rd, Sawyer TK, Frame MC. Identification of Src-specific phosphorylation site on focal adhesion kinase: dissection of the role of Src SH2 and catalytic functions and their consequences for tumor cell behavior. Cancer Res. 2005;65:1335\u201342.","journal-title":"Cancer Res"},{"key":"286_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1083\/jcb.200807096","volume":"184","author":"MR Dohn","year":"2009","unstructured":"Dohn MR, Brown MV, Reynolds AB. An essential role for p120-catenin in Src- and Rac1-mediated anchorage-independent cell growth. J Cell Biol. 2009;184:437\u201350.","journal-title":"J Cell Biol"},{"key":"286_CR17","doi-asserted-by":"publisher","first-page":"28006","DOI":"10.1074\/jbc.M102443200","volume":"276","author":"DJ Mariner","year":"2001","unstructured":"Mariner DJ, Anastasiadis P, Keilhack H, Bohmer FD, Wang J, Reynolds AB. Identification of Src phosphorylation sites in the catenin p120ctn. J Biol Chem. 2001;276:28006\u201313.","journal-title":"J Biol Chem"},{"key":"286_CR18","doi-asserted-by":"publisher","first-page":"e69023","DOI":"10.1371\/journal.pone.0069023","volume":"8","author":"N Bernardes","year":"2013","unstructured":"Bernardes N, Ribeiro AS, Abreu S, Mota B, Matos RG, Arraiano CM, Seruca R, Paredes J, Fialho AM. The bacterial protein azurin impairs invasion and FAK\/Src signaling in P-cadherin-overexpressing breast cancer cell models. PLoS One. 2013;8:e69023.","journal-title":"PLoS One"},{"key":"286_CR19","doi-asserted-by":"publisher","first-page":"8309","DOI":"10.1158\/0008-5472.CAN-04-0795","volume":"64","author":"J Paredes","year":"2004","unstructured":"Paredes J, Stove C, Stove V, Milanezi F, Van Marck V, Derycke L, Mareel M, Bracke M, Schmitt F. P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells. Cancer Res. 2004;64:8309\u201317.","journal-title":"Cancer Res"},{"key":"286_CR20","unstructured":"The Cancer Cell Line Encyclopedia (CCLE) [\n                    http:\/\/www.broadinstitute.org\/ccle\n                    \n                  ]."},{"key":"286_CR21","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/ejhg.2014.240","volume":"23","author":"JM Sanches","year":"2015","unstructured":"Sanches JM, Figueiredo J, Fonseca M, Duraes C, Melo S, Esmenio S, Seruca R. Quantification of mutant E-cadherin using bioimaging analysis of in situ fluorescence microscopy. A new approach to CDH1 missense variants. Eur J Hum Genet. 2015;23:1072\u20139.","journal-title":"Eur J Hum Genet"},{"key":"286_CR22","doi-asserted-by":"publisher","first-page":"19390","DOI":"10.1039\/C6NR04465D","volume":"8","author":"AS Ribeiro","year":"2016","unstructured":"Ribeiro AS, Carvalho FA, Figueiredo J, Carvalho R, Mestre T, Monteiro J, Guedes AF, Fonseca M, Sanches J, Seruca R, et al. Atomic force microscopy and graph analysis to study the P-cadherin\/SFK mechanotransduction signalling in breast cancer cells. Nanoscale. 2016;8:19390\u2013401.","journal-title":"Nanoscale"},{"key":"286_CR23","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1158\/0008-5472.CAN-06-3633","volume":"67","author":"F Huang","year":"2007","unstructured":"Huang F, Reeves K, Han X, Fairchild C, Platero S, Wong TW, Lee F, Shaw P, Clark E. Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selection. Cancer Res. 2007;67:2226\u201338.","journal-title":"Cancer Res"},{"key":"286_CR24","doi-asserted-by":"publisher","first-page":"6658","DOI":"10.1021\/jm049486a","volume":"47","author":"LJ Lombardo","year":"2004","unstructured":"Lombardo LJ, Lee FY, Chen P, Norris D, Barrish JC, Behnia K, Castaneda S, Cornelius LA, Das J, Doweyko AM, et al. Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src\/Abl kinase inhibitor with potent antitumor activity in preclinical assays. J Med Chem. 2004;47:6658\u201361.","journal-title":"J Med Chem"},{"key":"286_CR25","doi-asserted-by":"publisher","first-page":"R255","DOI":"10.1186\/gb-2007-8-11-r255","volume":"8","author":"XD Wang","year":"2007","unstructured":"Wang XD, Reeves K, Luo FR, Xu LA, Lee F, Clark E, Huang F. Identification of candidate predictive and surrogate molecular markers for dasatinib in prostate cancer: rationale for patient selection and efficacy monitoring. Genome Biol. 2007;8:R255.","journal-title":"Genome Biol"},{"key":"286_CR26","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jcp.2007.052704","volume":"61","author":"J Paredes","year":"2008","unstructured":"Paredes J, Correia AL, Ribeiro AS, Milanezi F, Cameselle-Teijeiro J, Schmitt FC. Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival. J Clin Pathol. 2008;61:856\u201362.","journal-title":"J Clin Pathol"},{"key":"286_CR27","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1078\/0344-0338-00338","volume":"198","author":"J Paredes","year":"2002","unstructured":"Paredes J, Milanezi F, Reis-Filho JS, Leitao D, Athanazio D, Schmitt F. Aberrant P-cadherin expression: is it associated with estrogen-independent growth in breast cancer? Pathol Res Pract. 2002;198:795\u2013801.","journal-title":"Pathol Res Pract"},{"key":"286_CR28","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4161\/cam.5.4.17290","volume":"5","author":"A Serrels","year":"2011","unstructured":"Serrels A, Canel M, Brunton VG, Frame MC. Src\/FAK-mediated regulation of E-cadherin as a mechanism for controlling collective cell movement: insights from in vivo imaging. Cell Adhes Migr. 2011;5:360\u20135.","journal-title":"Cell Adhes Migr"},{"key":"286_CR29","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/onc.2017.355","volume":"37","author":"Y Idoux-Gillet","year":"2018","unstructured":"Idoux-Gillet Y, Nassour M, Lakis E, Bonini F, Theillet C, Du Manoir S, Savagner P. Slug\/Pcad pathway controls epithelial cell dynamics in mammary gland and breast carcinoma. Oncogene. 2018;37:578\u201388.","journal-title":"Oncogene"},{"key":"286_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10549-013-2421-5","volume":"138","author":"S Bayraktar","year":"2013","unstructured":"Bayraktar S, Gluck S. Molecularly targeted therapies for metastatic triple-negative breast cancer. Breast Cancer Res Treat. 2013;138:21\u201335.","journal-title":"Breast Cancer Res Treat"},{"key":"286_CR31","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/annonc\/mdn291","volume":"19","author":"RS Finn","year":"2008","unstructured":"Finn RS. Targeting Src in breast cancer. Ann Oncol. 2008;19:1379\u201386.","journal-title":"Ann Oncol"},{"key":"286_CR32","doi-asserted-by":"publisher","first-page":"6061","DOI":"10.1158\/1078-0432.CCR-11-1071","volume":"17","author":"CI Herold","year":"2011","unstructured":"Herold CI, Chadaram V, Peterson BL, Marcom PK, Hopkins J, Kimmick GG, Favaro J, Hamilton E, Welch RA, Bacus S, Blackwell KL. Phase II trial of dasatinib in patients with metastatic breast cancer using real-time pharmacodynamic tissue biomarkers of Src inhibition to escalate dosing. Clin Cancer Res. 2011;17:6061\u201370.","journal-title":"Clin Cancer Res"},{"key":"286_CR33","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1158\/1078-0432.CCR-12-0652","volume":"19","author":"G Somlo","year":"2013","unstructured":"Somlo G, Atzori F, Strauss LC, Geese WJ, Specht JM, Gradishar WJ, Rybicki A, Sy O, Vahdat LT, Cortes J. Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004. Clin Cancer Res. 2013;19:1884\u201393.","journal-title":"Clin Cancer Res"},{"key":"286_CR34","doi-asserted-by":"publisher","first-page":"e0150360","DOI":"10.1371\/journal.pone.0150360","volume":"11","author":"A Herland","year":"2016","unstructured":"Herland A, van der Meer AD, FitzGerald EA, Park TE, Sleeboom JJ, Ingber DE. Distinct contributions of astrocytes and Pericytes to Neuroinflammation identified in a 3D human blood-brain barrier on a Chip. PLoS One. 2016;11:e0150360.","journal-title":"PLoS One"},{"key":"286_CR35","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1053\/j.gastro.2010.03.034","volume":"139","author":"JP Morton","year":"2010","unstructured":"Morton JP, Karim SA, Graham K, Timpson P, Jamieson N, Athineos D, Doyle B, McKay C, Heung MY, Oien KA, et al. Dasatinib inhibits the development of metastases in a mouse model of pancreatic ductal adenocarcinoma. Gastroenterology. 2010;139:292\u2013303.","journal-title":"Gastroenterology"},{"key":"286_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1023\/A:1023772912750","volume":"22","author":"JM Summy","year":"2003","unstructured":"Summy JM, Gallick GE. Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev. 2003;22:337\u201358.","journal-title":"Cancer Metastasis Rev"},{"key":"286_CR37","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nrc1366","volume":"4","author":"TJ Yeatman","year":"2004","unstructured":"Yeatman TJ. A renaissance for SRC. Nat Rev Cancer. 2004;4:470\u201380.","journal-title":"Nat Rev Cancer"},{"key":"286_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1242\/jcs.100115","volume":"126","author":"M Canel","year":"2013","unstructured":"Canel M, Serrels A, Frame MC, Brunton VG. E-cadherin-integrin crosstalk in cancer invasion and metastasis. J Cell Sci. 2013;126:393\u2013401.","journal-title":"J Cell Sci"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-018-0286-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12964-018-0286-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-018-0286-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T19:09:49Z","timestamp":1573067389000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-018-0286-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,7]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["286"],"URL":"https:\/\/doi.org\/10.1186\/s12964-018-0286-2","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,7]]},"assertion":[{"value":"22 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study using human tumor samples was conducted under the national regulative law for the handling of biological specimens from tumor banks, being the samples exclusively available for research purposes in retrospective studies, as well as under the international Helsinki declaration.Animal experiments were carried out in accordance with the European Guidelines for the Care and Use of Laboratory Animals, Directive 2010\/63\/UE and the National Regulation published in 2013 (Decreto-Lei n.\u00b0 113\/2013 de 7 de Agosto). All experimental procedures were approved by ORBEA (Org\u00e3o Respons\u00e1vel pelo Bem-Estar Animal da Faculdade de Medicina da Universidade do Porto\/Animal Welfare Body of the Medical Faculty of the University of Porto).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We have obtained consent to publish this paper from the participants of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"75"}}